OTC Markets OTCPK - Delayed Quote USD

Avivagen Inc. (VIVXF)

0.0012 -0.0052 (-81.25%)
At close: May 9 at 3:12 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
10/31/2022
10/31/2021
10/31/2020
10/31/2019
Total Revenue
715.2190
939.1730
1,295.9910
1,177.8570
977.4510
Cost of Revenue
409.8330
538.8740
761.6510
706.8770
450.9700
Gross Profit
305.3850
400.2990
534.3400
470.9800
526.4810
Operating Expense
1,504.9630
1,933.9960
1,891.9900
3,857.9730
4,419.3900
Operating Income
-1,199.5780
-1,533.6970
-1,357.6500
-3,386.9930
-3,892.9090
Net Non Operating Interest Income Expense
-1,721.0210
-1,168.4500
-2,246.5420
-1,337.0170
-893.5110
Other Income Expense
-1,717.0940
-3,364.0590
-2,789.9670
-27.2770
-50.0000
Pretax Income
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
-4,836.4200
Net Income Common Stockholders
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
-4,836.4200
Diluted NI Available to Com Stockholders
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
-4,836.4200
Basic EPS
-0.06
-0.09
-0.12
-0.12
-0.14
Diluted EPS
-0.06
-0.09
-0.12
-0.12
-0.14
Basic Average Shares
69,374.2270
66,027.8610
52,444.1570
40,307.5790
34,364.4250
Diluted Average Shares
69,374.2270
66,027.8610
52,444.1570
40,307.5790
34,364.4250
Total Expenses
1,914.7960
2,472.8700
2,653.6410
4,564.8500
4,870.3600
Net Income from Continuing & Discontinued Operation
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
-4,836.4200
Normalized Income
-2,922.8070
-2,702.1470
-3,644.1920
-4,751.2870
-4,836.4200
Interest Income
0.3520
0.6800
4.6910
9.0070
--
Interest Expense
1,861.1380
1,768.6170
1,586.0300
1,215.2400
925.8560
Net Interest Income
-1,721.0210
-1,168.4500
-2,246.5420
-1,337.0170
-893.5110
EBIT
-2,778.7630
-4,297.5890
-4,808.1290
-3,536.0470
-3,910.5640
EBITDA
-2,717.3740
-4,210.0900
-4,683.3550
-3,408.5540
-3,905.9280
Reconciled Cost of Revenue
409.8330
538.8740
761.6510
706.8770
450.9700
Reconciled Depreciation
61.3890
87.4990
124.7740
127.4930
4.6360
Net Income from Continuing Operation Net Minority Interest
-4,639.9010
-6,066.2060
-6,394.1590
-4,751.2870
-4,836.4200
Total Unusual Items Excluding Goodwill
-1,717.0940
-3,364.0590
-2,749.9670
--
--
Total Unusual Items
-1,717.0940
-3,364.0590
-2,749.9670
--
--
Normalized EBITDA
-1,000.2800
-846.0310
-1,933.3880
-3,408.5540
-3,905.9280
10/31/2019 - 5/2/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SMDPY Sumitomo Pharma Co., Ltd.
1.9900
-4.78%
 
SHPHF Sihuan Pharmaceutical Holdings Group Ltd.
0.0650
+13.04%
 
ORXOY Orexo AB (publ)
1.6500
+17.86%
 
ROMJF Rubicon Organics Inc.
0.3382
+2.77%
 
AOXG Aoxing Pharmaceutical Company, Inc.
0.0040
0.00%
 
XTXXF Adastra Holdings Ltd.
0.1850
+194.12%
 
DLTNF Delta 9 Cannabis Inc.
0.0126
-3.08%
 
TKPHF Takeda Pharmaceutical Company Limited
25.96
-0.38%
 
3737.HK Zhongzhi Pharmaceutical Holdings Limited
1.000
+3.09%
 
AYURF Ayurcann Holdings Corp.
0.0326
+0.15%